Navigation Links
Study of tiny magnets may advance their use in microelectronics
Date:10/19/2010

This release is also available in Chinese on EurekAlert! Chinese.

Washington, D.C. (October 19, 2010) -- In the world of the very small, researchers at Shanxi University in China have announced progress in understanding the single-molecule magnet, which combines the classical macroscale properties of a magnet with the quantum properties of a nanoscale entity. In the Journal of Applied Physics, Hai-Bin Xue and colleagues studied the statistics of how electrons move through a single-molecule magnet to better understand the magnet's inner level structure.

Understanding the single-molecule magnet inner level structure is an important step toward the development of revolutionary ways to store and process information, as well as quantum computation. The results are important to the field of molecular spintronics, which combines molecular electronics with the field of spintronics -- the manipulation of spin and charge.

"The single-molecule magnet can be regarded as a magnetic quantum dot with a more complex level structure," says co-author Yi-Hang Nie, "which makes it a good candidate for molecular spintronics devices."

How electrons move through single-molecule magnets is not well understood. "The current-voltage characteristics of such a system are not known well enough for practical application," says co-author Hai Bin Xue. "Our results go significantly beyond earlier studies of magnetic molecules in general, for which the current noise has been studied very little. The predictions permit experimental tests in the near future."


'/>"/>

Contact: Jason Bardi
jbardi@aip.org
301-209-3091
American Institute of Physics
Source:Eurekalert

Page: 1

Related biology news :

1. BMC receives National Institutes of Health grant to study intrauterine cocaine and substance reslience
2. CRN responds to JAMA fish oil study
3. Singapore scientists first to perform genome-wide study of human stem cells
4. Shifting forms: Penn study shows how variations of same protein affect immune response
5. First babies born from genetic screening study
6. NSF grant to study national energy policy and technology impacts
7. Florida State study finds watermelon lowers blood pressure
8. NSF awards grants to study effects of ocean acidification
9. Queens University Belfast lung injury study could save lives in critically ill
10. Study finds monarch butterflies use medicinal plants to treat offspring for disease
11. Scripps Research study challenges conventional theory of modern drug design
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/15/2016)... CHICAGO , April 15, 2016  A ... companies make more accurate underwriting decisions in a ... offering timely, competitively priced and high-value life insurance ... health screenings. With Force Diagnostics, rapid ... and lifestyle data readings (blood pressure, weight, pulse, ...
(Date:4/14/2016)... 2016 BioCatch ™, the ... announced the appointment of Eyal Goldwerger as ... Goldwerger,s leadership appointment comes at a time of ... deployment of its platform at several of the world,s ... discerns unique cognitive and physiological factors, is a winner ...
(Date:3/31/2016)... , March 31, 2016 ... ) ("LegacyXChange" or the "Company") LegacyXChange is ... users of its soon to be launched online site ... https://www.youtube.com/channel/UCyTLBzmZogV1y2D6bDkBX5g ) will also provide potential shareholders ... of DNA technology to an industry that is notorious ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... --  EpiBiome , a precision microbiome engineering company, today ... from Silicon Valley Bank (SVB). The financing will allow ... drug development efforts, as well as purchase additional lab ... been an incredible strategic partner to us – one ... provide," said Dr. Aeron Tynes Hammack , EpiBiome,s ...
(Date:6/23/2016)... ... ... STACS DNA Inc., the sample tracking software company, today announced that Dr. ... STACS DNA as a Field Application Specialist. , “I am thrilled that Dr. ... STACS DNA. “In further expanding our capacity as a scientific integrator, Hays brings a ...
(Date:6/23/2016)... June 23, 2016 Apellis Pharmaceuticals, Inc. ... clinical trials of its complement C3 inhibitor, APL-2. ... multiple ascending dose studies designed to assess the ... subcutaneous injection in healthy adult volunteers. ... as a single dose (ranging from 45 to ...
(Date:6/23/2016)... June 23, 2016 ... 2016;12(1):22-8 http://doi.org/10.17925/OHR.2016.12.01.22 Published recently ... peer-reviewed journal from touchONCOLOGY, Andrew D Zelenetz ... of cancer care is placing an increasing burden ... expensive biologic therapies. With the patents on many ...
Breaking Biology Technology: